131.30
前日終値:
$131.50
開ける:
$131.68
24時間の取引高:
6.15M
Relative Volume:
0.88
時価総額:
$228.44B
収益:
$42.34B
当期純損益:
$13.50B
株価収益率:
17.03
EPS:
7.71
ネットキャッシュフロー:
$6.66B
1週間 パフォーマンス:
-2.60%
1か月 パフォーマンス:
+1.12%
6か月 パフォーマンス:
+11.50%
1年 パフォーマンス:
+25.97%
Abbott Laboratories Stock (ABT) Company Profile
名前
Abbott Laboratories
セクター
電話
(224) 667-6100
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ABT
Abbott Laboratories
|
131.30 | 234.53B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.50 | 156.88B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
376.62 | 150.65B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
80.68 | 110.81B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
74.99 | 45.75B | 5.54B | 4.18B | 623.10M | 7.00 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-10-08 | 開始されました | Oppenheimer | Outperform |
2024-09-19 | 開始されました | Piper Sandler | Overweight |
2024-07-30 | ダウングレード | Edward Jones | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2023-07-21 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2023-05-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2023-04-20 | 繰り返されました | Barclays | Overweight |
2023-04-20 | 繰り返されました | Bernstein | Outperform |
2023-04-20 | 繰り返されました | JP Morgan | Overweight |
2023-04-20 | 繰り返されました | Raymond James | Outperform |
2023-04-20 | 繰り返されました | UBS | Buy |
2023-04-20 | 繰り返されました | Wolfe Research | Underperform |
2023-03-29 | 開始されました | UBS | Buy |
2022-10-26 | 開始されました | Mizuho | Neutral |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Hold |
2022-07-06 | 開始されました | Wolfe Research | Underperform |
2022-03-02 | 再開されました | BofA Securities | Buy |
2022-01-27 | 繰り返されました | Credit Suisse | Outperform |
2022-01-27 | 繰り返されました | Morgan Stanley | Overweight |
2022-01-27 | 繰り返されました | Raymond James | Outperform |
2022-01-27 | 繰り返されました | UBS | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-10-27 | アップグレード | Atlantic Equities | Neutral → Overweight |
2021-10-14 | 開始されました | Redburn | Neutral |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Neutral |
2021-01-28 | アップグレード | BTIG Research | Neutral → Buy |
2020-09-11 | 開始されました | Wolfe Research | Outperform |
2020-06-01 | ダウングレード | Goldman | Neutral → Sell |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Neutral |
2020-01-02 | ダウングレード | Guggenheim | Buy → Neutral |
2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
2019-02-07 | 繰り返されました | BofA/Merrill | Buy |
2019-01-02 | ダウングレード | Citigroup | Neutral → Sell |
2018-11-30 | アップグレード | Goldman | Neutral → Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-01-30 | 繰り返されました | Citigroup | Neutral |
2018-01-25 | 繰り返されました | Stifel | Buy |
2018-01-25 | アップグレード | William Blair | Mkt Perform → Outperform |
2018-01-03 | 開始されました | Evercore ISI | Outperform |
2018-01-02 | アップグレード | JP Morgan | Neutral → Overweight |
2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2017-10-19 | 繰り返されました | RBC Capital Mkts | Outperform |
2017-10-19 | 繰り返されました | Stifel | Buy |
すべてを表示
Abbott Laboratories (ABT) 最新ニュース
If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? - Yahoo Finance
Abbott Laboratories (ABT) Benefitted From Better Execution - MSN
STHS unveils groundbreaking lab upgrade from Abbott at St. Tammany Parish Hospital - an17.com
Abbott Laboratories (NYSE:ABT) Collaborates On Advanced Diabetes Management With Glucose-Ketone Sensor Integration - simplywall.st
Abbott Laboratories (ABT) was up 16% in Q1 - Insider Monkey
Was Jim Cramer Right About Abbott Laboratories (ABT)? - Insider Monkey
2 Dividend Stocks to Buy With $500 and Hold Forever - The Motley Fool
Blood Glucose Monitoring (BGM) Devices Market Report 2025: Hospitals Lead in Blood Glucose Monitoring Device Usage, Home Care Grows Fastest - GlobeNewswire Inc.
From Acquisition to Advantage: Abbott's Growth in Heart Care - Yahoo Finance
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better? - TradingView
Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories - Nasdaq
The Growth Of Medical Devices Needs To Continue In Order To Invest In Abbott (NYSE:ABT) - Seeking Alpha
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Do Abbott Laboratories' (NYSE:ABT) Earnings Warrant Your Attention? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Alcon (ALC) - The Globe and Mail
Solid Results Boosted Abbott Laboratories’ (ABT) Performance in Q1 - Insider Monkey
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? - Nasdaq
Biotechnology Market Set to Witness Significant Growth by 2025-2032 | Abbott Laboratories, Amgen Inc., - EIN News
United States Generic Drugs Market Forecast and Company Analysis Report 2025-2033 Featuring Teva Pharma, Aurobindo Pharma, Sun Pharma, Abbott Laboratories, Lupin Pharma, Viatris, Sandoz, Dr. Reddy'sResearchAndMarkets.com - FinancialContent
Abbott Laboratories (ABT)’s Libre Linked to Fewer Heart Hospitalizations in Diabetes - MSN
Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs - Zacks Investment Research
Abbott and Epic Collaborate to Streamline Glucose Data Access for Providers - The Healthcare Technology Report.
Abbott Laboratories' segment revenues from 2017 to 2024 - Statista
3 Magnificent Stocks That Are Passive Income Machines - The Globe and Mail
Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
North America Weight Management Products Market Report 2025-2033 Featuring Abbott, Nestle, Herbalife, Woodbolt, Premier Nutrition, Iovate, Kellogg, Ultimate Nutrition, Simply Good Foods, GlanbiaResearchAndMarkets.com - FinancialContent
United States Nutraceuticals Market Forecast Report 2025-2033 Featuring PepsiCo, General Mills, Nestle, Kellogg, Herbalife, Danone, Now Foods, Alticor, Red Bull, and Abbott Laboratories - GlobeNewswire
Europe Meal Replacement Products Market Forecast Report 2025-2033 Featuring Abbott Laboratories, Amway, Herbalife, The Simply Good Foods Co, Nestle, Peeroton, Huel, THG, USN, and Abnormal - Yahoo
Abbott India rises after Q4 PAT jumps 28% YoY to Rs 367 cr; declares dividend of Rs 475 /sh - Business Standard
Abbott studies show CGM users have fewer hospitalizations - BioWorld MedTech
Senseonics Kicks Off $50 Million Stock Offering; Discloses Private Placement of Up to $25 Million With Abbott Laboratories - marketscreener.com
Senseonics Holdings Inc Enters Securities Purchase Agreement With Abbott - marketscreener.com
Senseonics ticks down after announcing stock sale, private placement with Abbott - TradingView
Senseonics Holdings Enters Agreement with Abbott Laboratories - TipRanks
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Senseonics Announces Commencement of $50 Million Public - GlobeNewswire
Senseonics Secures $75M Financing Deal: Abbott Joins with $25M Strategic Investment for CGM Launch - Stock Titan
Abbott Laboratories (NYSE:ABT) Announces Libre Technology Reduces Heart Hospitalization Risk for Diabetics - simplywall.st
MotoAmerica is Changing Concussion Safety - marketscreener.com
Abbott’s Libre technology reduces heart hospitalization in real-world study - TipRanks
Abbott Says Libre Monitoring Linked to Fewer Heart-Related Hospitalizations for Diabetes - marketscreener.com
Abbott (ABT) Shows CGM Technology Reduces Heart Hospitalization Risks | ABT Stock News - GuruFocus
Abbott India's quarterly profit climbs 28% on strong demand - Reuters
Key Insights on Abbott Laboratories (ABT) Options Activity | ABT Stock News - GuruFocus
Abbott Announces New Positive Data From REFLECT Studies Of FreeStyle Libre CGM - Nasdaq
Abbott Laboratories' (NYSE:ABT) institutional investors lost 4.0% last week but have benefitted from longer-term gains - Yahoo Finance
Abbott Launches India’s First Flexible Tip Catheter To Treat AFib - BW Healthcare World
Abbott Labs Diagnostics Chief Andrea Wainer Strengthens Neogen Board with 25-Year Industry Expertise - Stock Titan
Fund Update: CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM added 2,040,913 shares of ABBOTT LABORATORIES ($ABT) to their portfolio - Nasdaq
Low-Calorie Food Market Top PlayersAbbott Laboratories, - openPR.com
Is Abbott Laboratories' (NYSE:ABT) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
Abbott Laboratories (ABT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):